Premium
Low levels of anti–SARS–CoV ‐2 antibodies after vaccination in rituximab‐treated patients: comment on the article by Simon et al
Author(s) -
Evangelatos Gerasimos,
Kouna Konstantina,
Fragoulis George E.,
Moschopoulou Melina,
Triantafylli Maria,
Lekka Antigoni,
Iliopoulos Alexios
Publication year - 2022
Publication title -
arthritis and rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.106
H-Index - 314
eISSN - 2326-5205
pISSN - 2326-5191
DOI - 10.1002/art.42011
Subject(s) - covid-19 , rituximab , antibody , virology , vaccination , medicine , immunology , disease , infectious disease (medical specialty) , outbreak